Sunshine Biopharma Inc. (SBFM): Depreciation & Amortization
$332.1K
Year ended 2025-12-31
+136.3%
3-year compound annual growth
+88.2%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $332.1K | +48.6% | 2026-04-03, From 2025-01-01 |
| 2024-12-31 | $223.5K | +49.9% | 2026-04-03, From 2024-01-01 |
| 2023-12-31 | $149.1K | +492.7% | 2025-04-01, From 2023-01-01 |
| 2022-12-31 | $25.2K | +97.5% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $12.7K | -9.4% | 2023-04-04, From 2021-01-01 |
| 2020-12-31 | $14.1K | +2.1% | 2022-03-21, From 2020-01-01 |
| 2019-12-31 | $13.8K | -72.1% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $49.4K | +644.6% | 2020-05-01, From 2018-01-01 |
| 2017-12-31 | $6.6K | -89.1% | 2019-04-12, From 2017-01-01 |
| 2016-12-31 | $60.7K | n/m | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $4.3K | n/a | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | $0 | n/a | 2016-03-25, From 2014-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $332.1K | +48.6% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $552.9K | +6.2% |
| Earth Science Tech, Inc. (ETST) | 2026-03-31 | $284.4K | +427.1% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $1.46M | +18.3% |
| Bioharvest Sciences Inc. (BHST) | 2025-12-31 | $1.62M | +29.8% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $138.0K | -67.2% |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | $3.33M | +6.8% |
| Xilio Therapeutics, Inc. (XLO) | 2025-12-31 | $1.54M | -6.3% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $4.15M | -15.4% |
Compare SBFM, LIFD, ETST, BGM side by side · Screen every company in Pharmaceutical Preparations ↗